ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
RIME
Algorhythm Holdings, Inc.
There isn't enough reported data to score RIME yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
RIME Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Healthy |
RIME's balance sheet is currently healthy, but its revenue, profitability and cash flow are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
RIME PE Valuation
RIME has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
RIME Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect RIME's losses to shrink, with revenue growing.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
RIME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$3.14 | +$328.44 |
| Q1 2026 | -$3.13 | +$518.21 |
| Q4 2025 | -$7.27 | +$583.41 |
| Q3 2025 | -$358.73 | +$2.86 |
| Q2 2025 | -$331.58 | +$52.01 |
| Q1 2025 | -$521.34 | -$199.75 |
| Q4 2024 | -$590.68 | -$123.09 |
| Q3 2024 | -$361.59 | +$106.41 |
RIME has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over RIME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
RIME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3M | +11% |
| Q1 2026 | $2.4M | +20% |
| Q4 2025 | $1.4M | -83% |
| Q3 2025 | $1.7M | -84% |
| Q2 2025 | $2.7M | +11% |
| Q1 2025 | $2M | -18% |
| Q4 2024 | $8M | -25% |
| Q3 2024 | $10.6M | -33% |
RIME's revenue is recovering but still below its 2020 peak: $3M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -90% | -61 points |
| Q1 2026 | -181% | -40 points |
| Q4 2025 | -296% | -212 points |
| Q3 2025 | -90% | -102 points |
| Q2 2025 | -29% | +223 points |
| Q1 2025 | -141% | -47 points |
| Q4 2024 | -84% | -48 points |
| Q3 2024 | 12% | +11 points |
RIME has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
RIME has the stronger cash trend. Its trailing FCF is down 354% versus its history, compared with ASTS at down 363%.
RIME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$3.9M | -$828K |
| Q4 2025 | -$3M | -$1.5M |
| Q3 2025 | $1.1M | +$2.8M |
| Q4 2024 | -$1.5M | -194% |
| Q3 2024 | -$1.7M | -228% |
| Q4 2023 | $1.6M | +26% |
| Q3 2023 | $1.3M | +168% |
| Q2 2023 | -$2.6M | +$1.6M |
RIME has burned cash in most quarters: −$8M over the past year, against −$5M the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over RIME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
RIME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +53% | +5.3M shares |
| 1 year | +513% | +12.7M shares |
| 3 years | +96818% | +15.1M shares |
| 5 years | +232307% | +15.1M shares |
| Available history | +230925% | +15.1M shares |
RIME has 15M diluted shares, up 513% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RIME Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -0.2x | Net Cash |
| Q2 2022 | 0.6x | Very low |
| Q1 2022 | 0.8x | Very low |
| Q4 2021 | 2.5x | Moderate |
| Q3 2021 | -4.2x | Net Cash |
| Q2 2021 | -0.5x | Net Cash |
| Q1 2021 | 0.1x | Very low |
| Q4 2020 | -0.2x | Net Cash |
RIME has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
RIME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.9 | Neutral |
| Stochastic | 7.8 | Oversold |
RIME's weekly RSI is 34 (neutral) and its Stochastic is 8 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
RIME PE vs Technology Sector
| Metric | RIME | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
RIME has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
RIME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.13 | 7.7% above |
| 20 week MA | $0.28 | 50% below |
| 50 week MA | $0.82 | 83% below |
| 100 week MA | $2.45 | 94% below |
| 200 week MA | $124.4 | 100% below |
RIME has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 100% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over RIME on returns for 2026, with the stronger performance.
RIME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,441.4 | $1,982.0 | +38% |
| 2021 | $1,982.0 | $1,321.9 | -33% |
| 2022 | $1,321.9 | $998.0 | -25% |
| 2023 | $998.0 | $202.0 | -80% |
| 2024 | $202.0 | $16.8 | -92% |
| 2025 | $16.8 | $1.13 | -93% |
| 2026 YTD | $1.13 | $0.14 | -88% |
RIME has finished five years in a row lower, and it's down 88% so far in 2026.